A Great Find for Wholesale Buyers
The selection looks lovely, and I like the range of products included. It seems like a convenient option for anyone looking to expand their inventory.
Hakheem Wyatt · Nov 12, 2026Retatrutide is an experimental, synthetic triple-agonist peptide designed to target three primary metabolic receptors: GLP-1, GIP, and glucagon.
For laboratory research use only. Not intended for human consumption.
C221H342N46O68
=>99.4%
-20°C
6 days
Retatrutide (originally known as LY-3437943) is a highly effective, investigative multi-receptor agonist developed for the treatment of severe obesity and type 2 diabetes. By simultaneously activating the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R), it works comprehensively to suppress appetite, enhance feelings of fullness, delay gastric emptying, and significantly increase energy expenditure. Clinical data indicates it provides substantial weight reduction profiles and highly robust glycemic control compared to earlier single or dual-receptor therapies.
Retatrutide is an experimental, synthetic triple-agonist peptide designed to target three primary metabolic receptors: GLP-1, GIP, and glucagon.
Store in a cool, dry environment: -20°C.
The selection looks lovely, and I like the range of products included. It seems like a convenient option for anyone looking to expand their inventory.
Hakheem Wyatt · Nov 12, 2026Your review will be published after approval.
Every batch undergoes rigorous third-party analytical testing to confirm purity, identity, and consistency standards.
Download COA